• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Make a delay and accumulation of outstanding tasks Full stop
Biotech

Ionis scraps Alzheimer’s candidate for people with Down syndrome

The decision marks another setback for a group of patients who are both at higher risk for the disease and not served by currently approved therapies.
Darren Incorvaia Feb 20, 2026 1:50pm
multiple pairs of feet by a fireplace

How Biohaven is keeping its 'feet to the fire'

Feb 20, 2026 10:30am
Supreme Court building in Washington DC
Favicon Fierce Pharma

Supreme Court steps in: Trump's emergency tariffs struck down

Feb 20, 2026 11:33am
Yellow Paraglider Flying Over the Peaks of the French Alps

Roche taps Aussie oncologist to lead research—Chutes & Ladders

Feb 20, 2026 8:30am
blood test vials

Grail stock craters as Galleri trial fails to hit endpoint

Feb 20, 2026 7:30am
Daiichi

Daiichi picks former Novartis CMO John Tsai to head up R&D

Feb 20, 2026 4:56am
More News

Candel glows with $100M RTW deal to fund cancer drug launch

Feb 20, 2026 4:04am

Novartis jettisons ph. 1 cancer candidate after 0% efficacy

Feb 19, 2026 2:45pm

Trump met with Makary before FDA’s Moderna walkback: report

Feb 19, 2026 11:30am

Fierce Biotech Fundraising Tracker '26: Altesa; Korsana & more

Feb 19, 2026 10:30am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings